University of California San Francisco

Kayla Switalla, MD

Kayla Switalla
Kayla Switalla, MD

Resident (PGY-1)
General Surgery

[email protected]

Education

Institution Degree Dept or School End Date
University of Minnesota Medical School MD Medicine 05/2025
University of Minnesota Twin Cities BS Neuroscience 05/2019
University of Minnesota Twin Cities BA Psychology 05/2019

Awards & Honors

Award Conferred By Date
Alpha Omega Alpha University of Minnesota Medical School 2025
University of Minnesota Foundation Research Grant University of Minnesota Medical School 2024/2025
Outstanding Scientific Presentation Award by a Medical Trainee 25th American Society of Breast Surgeons Annual Meeting 2024
University of Minnesota Foundation Research Grant University of Minnesota Medical School 2023/2024

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 17
  1. Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Mukhtar RA, Dimitroff K, Yau C, Chien AJ, Connolly EP, Howard-McNatt M, Rao R, Ladores V, Golshan M, Sauder CA, Ahmed K, Lancaster R, Fox J, Gutnik L, Lee MC, Tchou J, Prionas N, Arciero CA, Reyna C, Kuerer H, Switalla K, Taunk N, Tuttle TM, Moran MS, Postlewait LM, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Rugo HS, Shatsky R, Isaacs C, Esserman LJ, Van't Veer L, Boughey JC| | PubMed
  2. Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
    Kaur M, Dimitroff K, Boughey JC, Esserman LJ, Yau C, Tchou J, Quirarte A, Lee MC, Howard-McNatt MM, Switalla K, Kuerer H, Sauder C, Postlewait LM, Arciero C, Rao R, Wallace A, Reyna C, Ahmed K, Gutnik L, Taunk N, Perlmutter J, DeMichele A, Yee D, Hylton NM, Symmans WF, Rugo HS, Shatsky RA, Isaacs C, Rudra S, Pohlmann P, Ewing C, Wong J, Alvarado M, Jaskowiak N, Prionas N, Golshan M, Piltin MA, Olopade OI, Mukhtar RA| | PubMed
  3. Risk Factors for Dyspnea in Rib Fracture Patients: A Prospective Study of Patient-Reported Outcomes.
    Switalla KM, Sundlof M, Jones E, Bahr M, Doering M, Martin D, McCormick-Deaton J, Melton-Meaux GB, Tignanelli C| | PubMed
  4. ASO Author Reflections: Reassessing Positive Margins in Breast-Conserving Surgery: The Role of Histology and Oncoplastic Surgery.
    Switalla KM, Mukhtar RA| | PubMed
  5. Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
    Switalla KM, Falade IO, Quirarte A, Baxter M, Kaur M, Sakr RA, Corso G, Mukhtar RA| | PubMed
  6. Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
    Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA, I-SPY2 Locoregional Working Group| | PubMed
  7. Efficacy of topical tranexamic acid in gender-affirming mastectomy.
    Falade I, Lopes A, Switalla K, Song S, Ramrakhiani N, Kim E| | PubMed
  8. Risk factors and resolution of patient-reported pain and mental health symptoms following rib fracture(s).
    Sundlof M, Switalla K, Jones EK, Bahr M, Doering M, Martin D, McCormick-Deaton J, Melton-Meaux GB, Tignanelli CJ| | PubMed
  9. Balancing risks of surgical complications and positive margins for patients with invasive lobular carcinoma of the breast and elevated BMI: An institutional cohort study.
    Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Alvarado M, Julian BQ, Ewing C, Wong J, Rose J, Esserman L, Foster R, Mukhtar RA| | PubMed
  10. Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast.
    Falade IO, Switalla KM, Baxter ME, Quirarte A, Record H, Rothschild HT, Clelland EN, Mukhtar RA| | PubMed
  11. ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
    Switalla KM, Boughey JC, Mukhtar RA| | PubMed
  12. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA| | PubMed
  13. Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
    Falade I, Switalla K, Quirarte A, Baxter M, Soroudi D, Rothschild H, Abe SE, Goodwin K, Piper M, Wong J, Foster R, Mukhtar RA| | PubMed
  14. Functional donor-site morbidity following reconstruction with pectoralis major flaps: A systematic review.
    Falade IO, Murphy AI, Switalla KM, Yin RR, Rose JA| | PubMed
  15. Effect of beta-blocker therapy on weight loss outcomes after sleeve gastrectomy & Roux-en-Y gastric bypass.
    Switalla K, Sundlof M, Abdelwahab H, Leslie D, Wise E, Wang Q, Duval S, Benner A, Bartolomucci A, Ikramuddin S| | PubMed
  16. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
    Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA| | PubMed
  17. Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives.
    Engelking M, Marmor S, Burjak M, Hinojos M, Lloyd W, Switalla KM, Tuttle TM| | PubMed